Becton, Dickinson and Company Prices Offerings Of $2.25 Billion Of Common Stock And $2.25 Billion Of Depositary Shares Representing Interests In Mandatory Convertible Preferred Stock Post author:Sam Post published:May 10, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Verastem Soars as Blood Cancer Drug Succeeds in Phase III Study September 5, 2017 Hill-Rom To Host Fiscal Fourth Quarter 2017 Earnings Conference Call And Webcast September 28, 2017 Edwards Lifesciences Corporation Release: German Patent Court Issues Initial Decision March 8, 2017